drugset / Trial / NCT01997853

Omega-3 Fatty Acids in Chronic Periodontitis.

NCT01997853

Phase 4 Completed 60 enrolled Tatyasaheb Kore Dental College
RandomizedParallel-groupTriple-blindTreatment

Summary

Omega 3 fatty acids is one such dietary supplement, known to modulate the host response in chronic conditions like cardiovascular diseases, rheumatoid arthritis, ischemic cerebrovascular diseases, osteoporosis by producing Resolvins and protectins without showing any inadvertent effects.Addition of systemic Omega 3 Fatty Acids with SRP may enhance the therapeutic result of Chronic Periodontitis owing to host modulation \& anti-inflammatory properties. If proven, this can be used as a routine treatment modality.

Timeline

Start
2012-07
Primary completion
2013-08
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lovaza Other / unclassified 300 mg

Indications